Position in BLLN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$833,132
-$33,471 QoQ
Shares Held
10,554
-0.3% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Bellevue Group AG holds $131,151,626 across 13 Diagnostics & Research names. BLLN ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
89,131 | $50,081,817 | |
| 2 | DHR |
Danaher Corp /De/
|
202,164 | $38,330,294 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
64,412 | $31,660,430 | |
| 4 | NTRA |
Natera, Inc.
|
31,694 | $6,338,483 | |
| 5 | ILMN |
Illumina, Inc.
|
20,223 | $2,492,686 | |
| 6 | ADPT |
Adaptive Biotechnologies Corp
|
76,181 | $1,057,392 | |
| 7 | BLLN |
BillionToOne, Inc.
This page
|
10,554 | $833,132 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
740 | $126,199 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $833,132 | 10,554 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $866,603 | 10,589 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||